NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

29 hedge funds and large institutions have $2.76M invested in Navidea Biopharmaceuticals Inc. in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 3 closing their positions.

Holders
29
Holders Change
-2
Holders Change %
-6.45%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
9
Closed
3
Calls
$250K
Puts
$619K
Net Calls
-$369K
Net Calls Change
-$188K

Top Buyers

1
Group One Trading
1
Group One Trading
Illinois
$17K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.29M
3
TRCT
3
Tower Research Capital (TRC)
New York
$11K
4
Osaic Holdings
4
Osaic Holdings
Arizona
$4K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$76K

Top Sellers

1
Two Sigma Advisers
1
Two Sigma Advisers
New York
$170K
2
Two Sigma Investments
2
Two Sigma Investments
New York
$119K
3
Citadel Advisors
3
Citadel Advisors
Florida
$74K
4
ACM
4
Allred Capital Management
Texas
$114K
5
Morgan Stanley
5
Morgan Stanley
New York
$5K
Name Holding Trade Value Shares
Change 		Shares
Change %
PA
26
Parallel Advisors
California
$1K – – –
KFS
27
Kelly Financial Services
Massachusetts
$88 -$74 -42 -46%
Citigroup
28
Citigroup
New York
– -$3K -1,912 Closed
1
2